Get started
Author

Mkhokheli Ngwenya

Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme
2015 · Kudakwashe C Takarinda, Anthony D Harries, et al. · BMC Public Health · 75
PDF
Catastrophic costs among tuberculosis‐affected households in Zimbabwe: A national health facility‐based survey
2021 · Collins Timire, Mkhokheli Ngwenya, et al. · Tropical Medicine & International Health · 44
PDF
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey
2019 · Collins Timire, John Z. Metcalfe, et al. · International Journal of Infectious Diseases · 23
PDF
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
2024 · The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, S.A. Adakun, et al. · IJTLD OPEN · 21
Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015
2020 · Ronnie Matambo, Kudakwashe C. Takarinda, et al. · PLoS ONE · 21
PDF
A feasibility study using time-driven activity-based costing as a management tool for provider cost estimation: lessons from the national TB control program in Zimbabwe in 2018
2021 · J. Chirenda, B. Nhlema Simwaka, et al. · BMC Health Services Research · 15
PDF
Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study
2025 · Ismael Maatouk, Phiona Vumbugwa, et al. · The Lancet Regional Health - Western Pacific · 13
PDF
Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain Line Probe Assay in Southern provinces, Zimbabwe
2019 · Collins Timire, Charles Sandy, et al. · International Journal of Infectious Diseases · 11
PDF
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
2025 · The Kenya, Uganda, Zambia and Zimbabwe TB Disability Study Group listed by surname alphabetically:, S.A. Adakun, et al. · IJTLD OPEN · 7
Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015
2021 · Ronnie Matambo, George Nyandoro, et al. · Pan African Medical Journal · 6
PDF
TB prevalence in Zimbabwe: a national cross-sectional survey, 2014
2021 · M. Chipinduro, C. Timire, et al. · The International Journal of Tuberculosis and Lung Disease · 4
Targeted active screening for tuberculosis in Zimbabwe: are field digital chest X-ray ratings reliable?
2019 · C. Timire, C. Sandy, et al. · Public Health Action · 3
Modeling one-stop-shop integration of family planning and HIV services in Zimbabwe, 2021
2023 · Hamufare Dumisani Mugauri, Ishmael Chikondowa, et al. · Journal of Reproductive Healthcare and Medicine · 2
Strengthening a collaborative approach to implementing surveillance systems: Lessons from the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Malawi and Zimbabwe
2024 · Phiona Vumbugwa, Ismael Maatouk, et al. · medRxiv
PDF
The role of bacteriological monitoring using culture and drug susceptibility tests (CDST) on treatment outcomes among MDR/RR-TB patients on treatment: a cohort analysis of patients enrolled on treatment 2010-2015 in Zimbabwe
2021 · Ronnie Matambo, Shungu Mutero-Munyati, et al. · Pan African Medical Journal
Predictors of mortality and treatment success of Multi- drug resistant and Rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015
2020 · Matambo, Ronnie, Nyandoro, George, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 16
Citation count: 245
H-index: 8
I10-index: 8
Year
Topic
Type